Effect of Prebiotics on Blood Pressure Management
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-65
SponsorSun Yat-sen University
About this trial
This survey is designed to investigate the effect of highland barley β-glucan supplementation on the regulatory of blood pressure, gut microbiota and cardiovascular risk fators in subjects with hypertention.
Eligibility criteria
Qualifiers
Age:30-65 years old
Newly diagnosed hypertension did not use antihypertensive drugs OR Systolic blood pressure ≥140mmHg on the physical examination OR Diastolic blood pressure ≥90mmHg on the physical examination.
BMI≥18 kg/m2
Disqualifiers
Receiving or have been treated with antihypertensive drugs.
Complications including cardiovascular and cerebrovascular diseases such as coronary heart disease and stroke.
Severe liver or renal insufficiency (alanine aminotransferase, aspartate aminotransferase or alkaline phosphatase is greater than 3 times the upper limit of normal OR GFR<30ml/min/1.73m2).
Autoimmune diseases or thyroid diseases.
Trial design
Treatments tested in this trial
- Highland barley β-glucan dietary supplement
- Placebo controls
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov